Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: Relationship with platelet count

Annals of Hematology

Volumn 69, Issue 2, 1994, Pages 81-84

  van Genderen, P J J ^a   Michiels, J J ^a   van der Poel van de Luytgaarde, S C P A M ^a   van Vliet, H H D M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acquired von Willebrand disease; Myeloproliferative disorder; Platelets Bleeding; Primary thrombocythemia; von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING; CASE REPORT; FEMALE; HUMAN; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTHEMIA; VON WILLEBRAND DISEASE;

ADULT; BLEEDING TIME; CASE REPORT; FEMALE; HEMORRHAGE; HUMAN; HYDROXYUREA; MUCOUS MEMBRANE; PLATELET COUNT; SKIN DISEASES; THROMBOCYTOSIS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0027968781     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/BF01698487     Document Type: Article

References (16)

1. Essential thrombocythemias: clinical, evolutionary and biological data
2. Visualization of von Willebrand factor multimers by enzymeconjugated secondary antibodies
3. An ELISA test for the binding of von Willebrand factor antigen to collagen
4. Acquired von Willebrand's disease in the myeloproliferative syndrome
5. Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome
6. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma
7. Enzyme immunoassay for factor VIII-related antigen
8. Clinical course of essential thrombocythemia in 147 cases
9. The standardization of certain factors in the cutaneous ‘venostasis’ bleeding time technique
10. Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis
11. A method for assaying von Willebrand factor (ristocetin cofactor)
12. Plasma von Willebrand factor abnormalities in patients with essential thrombocythemia
13. Essential thrombocythemia
14. Plasma von Willebrand factor proteolysis in patients with chronic myeloproliferative disorders: no possibility of ex vivo degradation by calcium-dependent proteases
15. Primary thrombocythemia: diagnosis, clinical manifestations and management
16. Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia